Announcements Trials
Browse Landscape

Status

Completed 5Unknown 2Terminated 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 40Head & Neck 23Thoracic 16Sarcoma 14Breast 12Genitourinary 10CNS 9Gynecologic 6Dermatologic 6Tumor-Agnostic 4Other neoplasm 1Endocrine 1

Conditions

Pituitary Neoplasms 1

Interventions

lutetium Lu 177 dotatate 16Magnetic Resonance Spectroscopy 14gallium Ga 68 dotatate 9Specimen Handling 8Everolimus 8pembrolizumab 7cabozantinib 6Cisplatin 6fluorodopa F 18 5Etoposide 5trametinib 4surufatinib 4lanreotide 4dabrafenib 4cemiplimab 4X-Rays 4Temozolomide 4Nivolumab 4Lutetium-177 4Lutetium 4Fluorodeoxyglucose F18 4Carboplatin 4177Lu-octreotide, DOTA(0)-Tyr(3)- 4olaparib 3lenvatinib 3copper dotatate CU-64 3Transurethral Resection of Prostate 3Thyrotropin Alfa 3Surveys and Questionnaires 3Somatostatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Surgical Procedures, Operative × Endocrine × Clear all
NCT06705036 2024-11-26

Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions

Shanghai Zhongshan Hospital

Recruiting
20 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡